Alar Pharmaceuticals Inc. (TPEX:6785)
Taiwan
· Delayed Price · Currency is TWD 184.50
-7.50 (-3.91%)
Mar 9, 2026, 1:30 PM CST
Alar Pharmaceuticals Market Cap
Alar Pharmaceuticals has a market cap or net worth of 12.32 billion as of March 9, 2026. Its market cap has increased by 25.94% in one year.
Market Cap
12.32B
Enterprise Value
9.99B
Revenue
1.25M
Ranking
n/a
PE Ratio
n/a
Stock Price
184.50
Market Cap Chart
Since October 5, 2020, Alar Pharmaceuticals's market cap has increased from 2.57B to 12.32B, an increase of 380.49%. That is a compound annual growth rate of 33.60%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Foresee Pharmaceuticals | 12.86B |
| Handa Pharmaceuticals | 12.55B |
| Standard Chemical & Pharmaceutical | 11.54B |
| YungShin Global Holding | 14.46B |
| Synmosa Biopharma | 15.92B |
| ScinoPharm Taiwan | 17.12B |
| Grape King Bio | 17.85B |
| TTY Biopharm Company | 20.74B |